|
Feitelson, Mark A; Arzumanyan, Alla; Kulathinal, Rob J et al. (2015) Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol 35 Suppl:S25-S54
|
|
Schinazi, Raymond F; Bassit, Leda; Clayton, Marcia M et al. (2012) Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication. Antimicrob Agents Chemother 56:6186-91
|
|
Pan, Jingbo; Lian, Zhaorui; Wallett, Sarah et al. (2007) The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin. J Gen Virol 88:3275-85
|
|
Feitelson, Mark A; Clayton, Marcia M; Sun, Bill et al. (2007) Development of a novel mouse model to evaluate drug candidates against hepatitis B virus. Antivir Chem Chemother 18:213-23
|
|
Lian, Zhaorui; Liu, Jie; Wu, Mengchao et al. (2007) Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis. Hepatology 45:1390-9
|
|
Lian, Zhaorui; Liu, Jie; Li, Li et al. (2006) Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin. Hepatology 43:415-24
|
|
Liu, J; Lian, Z; Han, S et al. (2006) Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25:1008-17
|
|
Feitelson, Mark Alan; Reis, Helena M G P V; Liu, Jie et al. (2005) Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis. Front Biosci 10:1558-72
|
|
Feitelson, Mark A; Pan, Jingbo; Lian, Zhaorui (2004) Early molecular and genetic determinants of primary liver malignancy. Surg Clin North Am 84:339-54
|
|
Norton, P A; Reis, H M G P V; Prince, S et al. (2004) Activation of fibronectin gene expression by hepatitis B virus x antigen. J Viral Hepat 11:332-41
|
Showing the most recent 10 out of 27 publications
